The effect of melatonin cream on dermatitis
Phase 3
- Conditions
- Dermatitis.Diseases of the skin and subcutaneous tissue(L00-L99)L20-L30
- Registration Number
- IRCT20220403054394N1
- Lead Sponsor
- Karaj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
12 year-old or older patients with dermatitis which has affected at least 5% of whole body.
Written informed consent to participate in study
Exclusion Criteria
Patients receiving systemic treatment for their dermatitis (exception: antihistamines).
Patients receiving sedatives.
Patients with history of allergic reactions to Melatonin or other ingredients in creams.
If a patient refuses to continue the study at any time after the study started.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method esion severity in the dermatitis score questionnaire. Timepoint: At the beginning of the study and 21 days after starting the topical melatonin cream. Method of measurement: Severity Scoring of Atopic Dermatitis index (SCORAD) questionnaire.
- Secondary Outcome Measures
Name Time Method